ClinicalTrials.Veeva

Menu

The Effect of Maximum Body Weight in Lifetime on the Development of Type 2 Diabetes (MAXWEL)

Seoul National University logo

Seoul National University

Status

Completed

Conditions

Prediabetes
Diabetes

Study type

Observational

Funder types

Other

Identifiers

NCT00816608
MAXWEL 09

Details and patient eligibility

About

Hypothesis : The maximum body weight in lifetime is associated with the onset of development of type 2 diabetes.

Full description

Obesity is well recognized risk factor for type 2 diabetes. Recent studies reported that weight change, especially severe weight gain was associated with an increased risk of type 2 diabetes. The aim of this study is to investigate whether the maximum body weight of lifetime is associated with the early onset of type 2 diabetes or an increased risk of type 2 diabetes in Korean.

Enrollment

3,000 patients

Sex

All

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Korean with type 2 diabetes
  • Korean with confirmed IFG or IGT
  • Korean with NGT

Exclusion criteria

  • Malignancy except thyroid cancer
  • Active tuberculosis

Trial design

3,000 participants in 1 patient group

type 2 diabetes

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems